• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reply to Reske et al.: PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions.

作者信息

Afshar-Oromieh A, Malcher A, Eder M, Eisenhut M, Linhart H G, Hadaschik B A, Holland-Letz T, Giesel F L, Kratochwil C, Haufe S, Haberkorn U, Zechmann C M

出版信息

Eur J Nucl Med Mol Imaging. 2013 Jun;40(6):971-2. doi: 10.1007/s00259-013-2386-y. Epub 2013 Apr 5.

DOI:10.1007/s00259-013-2386-y
PMID:23558688
Abstract
摘要

相似文献

1
Reply to Reske et al.: PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions.对雷斯克等人的回复：使用[68Ga]镓标记的前列腺特异性膜抗原（PSMA）配体进行正电子发射断层扫描（PET）成像以诊断前列腺癌：人体生物分布及肿瘤病变的首次评估
Eur J Nucl Med Mol Imaging. 2013 Jun;40(6):971-2. doi: 10.1007/s00259-013-2386-y. Epub 2013 Apr 5.
2
Comment on Afshar-Oromieh et al.: PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions.对阿夫沙尔-奥罗米耶等人的评论：使用[68Ga]镓标记的前列腺特异性膜抗原（PSMA）配体进行PET成像诊断前列腺癌：人体生物分布及肿瘤病变的首次评估
Eur J Nucl Med Mol Imaging. 2013 Jun;40(6):969-70. doi: 10.1007/s00259-013-2385-z. Epub 2013 Apr 5.
3
PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions.用[68Ga]镓标记的 PSMA 配体进行 PET 成像诊断前列腺癌：在人体中的生物分布及对肿瘤病灶的初步评估。
Eur J Nucl Med Mol Imaging. 2013 Apr;40(4):486-95. doi: 10.1007/s00259-012-2298-2. Epub 2012 Nov 24.
4
[68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECH.[68Ga]镓标记的前列腺特异性膜抗原（PSMA）配体作为诊断前列腺癌的优质正电子发射断层显像（PET）示踪剂：与18F-FECH的比较
Eur J Nucl Med Mol Imaging. 2012 Jun;39(6):1085-6. doi: 10.1007/s00259-012-2069-0. Epub 2012 Feb 4.
5
Hybrid positron emission tomography-magnetic resonance imaging with gallium 68 prostate-specific membrane antigen tracer: a next step for imaging of recurrent prostate cancer-preliminary results.镓68前列腺特异性膜抗原示踪剂的正电子发射断层扫描-磁共振成像混合技术：复发性前列腺癌成像的下一步——初步结果
Eur Urol. 2013 Nov;64(5):862-4. doi: 10.1016/j.eururo.2013.08.003. Epub 2013 Aug 9.
6
[Ga-68-PSMA PET/CT for prostate cancer].[用于前列腺癌的镓-68-前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描]
Aktuelle Urol. 2014 Nov;45(6):457-63. doi: 10.1055/s-0034-1395529. Epub 2014 Dec 17.
7
Metastatic Prostate Carcinoma Presenting as a Superscan on 68Ga-PSMA PET/CT.前列腺癌转移，表现为 68Ga-PSMA PET/CT 全身扫描阳性。
Clin Nucl Med. 2015 Sep;40(9):755-6. doi: 10.1097/RLU.0000000000000870.
8
(68)Ga-PSMA PET/MR with multimodality image analysis for primary prostate cancer.用于原发性前列腺癌的（68）镓-前列腺特异性膜抗原正电子发射断层扫描/磁共振成像及多模态图像分析
Abdom Imaging. 2015 Aug;40(6):1769-71. doi: 10.1007/s00261-014-0301-z.
9
PET/MRI with a 68Ga-PSMA ligand for the detection of prostate cancer.使用68Ga-PSMA配体的PET/MRI用于前列腺癌检测。
Eur J Nucl Med Mol Imaging. 2013 Oct;40(10):1629-30. doi: 10.1007/s00259-013-2489-5. Epub 2013 Jul 2.
10
Whole-Body Integrated [Ga]PSMA-11-PET/MR Imaging in Patients with Recurrent Prostate Cancer: Comparison with Whole-Body PET/CT as the Standard of Reference.全身整合 [Ga]PSMA-11-PET/MR 成像在复发性前列腺癌患者中的应用：与全身 PET/CT 作为参考标准的比较。
Mol Imaging Biol. 2020 Jun;22(3):788-796. doi: 10.1007/s11307-019-01424-4.

引用本文的文献

1
The diagnosis and treatment of castrate-sensitive oligometastatic prostate cancer: A review.去势敏感性寡转移前列腺癌的诊断与治疗：综述
Prostate Cancer Prostatic Dis. 2023 Dec;26(4):702-711. doi: 10.1038/s41391-023-00688-w. Epub 2023 Jul 8.
2
68Ga-Prostate-specific membrane antigen (psma) positron emission tomography (pet) in prostate cancer: a systematic review and meta-analysis.68Ga-前列腺特异性膜抗原（PSMA）正电子发射断层扫描（PET）在前列腺癌中的应用：系统评价和荟萃分析。
Int Braz J Urol. 2021 Jul-Aug;47(4):705-729. doi: 10.1590/S1677-5538.IBJU.2019.0817.
3
Comparison of [Ga]Ga-PSMA-11 PET/CT with [F]NaF PET/CT in the evaluation of bone metastases in metastatic prostate cancer patients prior to radionuclide therapy.

本文引用的文献

1
Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastatic prostate cancer.18F-DCFBC（一种低分子量前列腺特异性膜抗原抑制剂）在转移性前列腺癌患者中的生物分布、肿瘤检测和辐射剂量学。
J Nucl Med. 2012 Dec;53(12):1883-91. doi: 10.2967/jnumed.112.104661.
2
PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions.用[68Ga]镓标记的 PSMA 配体进行 PET 成像诊断前列腺癌：在人体中的生物分布及对肿瘤病灶的初步评估。
Eur J Nucl Med Mol Imaging. 2013 Apr;40(4):486-95. doi: 10.1007/s00259-012-2298-2. Epub 2012 Nov 24.
镓-68 前列腺膜抗原-11 PET/CT 与氟-18 氟化钠 PET/CT 在前哨核素治疗转移性前列腺癌患者骨转移评估中的比较。
Eur J Nucl Med Mol Imaging. 2018 Oct;45(11):1873-1883. doi: 10.1007/s00259-018-4048-6. Epub 2018 May 16.
4
Scavenger Receptor-Mediated Targeted Treatment of Collagen-Induced Arthritis by Dextran Sulfate-Methotrexate Prodrug.硫酸葡聚糖-甲氨蝶呤前药通过清道夫受体介导的胶原诱导性关节炎靶向治疗
Theranostics. 2017 Jan 1;7(1):97-105. doi: 10.7150/thno.16844. eCollection 2017.
5
Preclinical Comparative Study of (68)Ga-Labeled DOTA, NOTA, and HBED-CC Chelated Radiotracers for Targeting PSMA.用于靶向前列腺特异性膜抗原的（68）镓标记的DOTA、NOTA和HBED-CC螯合放射性示踪剂的临床前比较研究
Bioconjug Chem. 2016 Jun 15;27(6):1447-55. doi: 10.1021/acs.bioconjchem.5b00679. Epub 2016 May 9.